Mindfulness Awareness Practices for ADHD (adapted)
BehavioralThe Mindful Awareness Practices (MAPs) for ADHD program is an 8-week, group-based mindfulness program for adults with ADHD.
NCT Number: NCT06076967
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD. If found to be feasible, acceptable, and efficacious, subsequent research will examine its impact on a larger scale to have a broader public health impact for college students with ADHD.
Interested in participating?
Request Info17 year–25 year
All sexes
Interventional
Not applicable
Department of Psychology, University of Alabama, Tuscaloosa, Alabama, United States
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood. Stimulant and non-stimulant pharmacotherapies are the mainstay of treatment; however, non- pharmacological interventions such as mindfulness have significant empirical support. The Mindful Awareness Practices (MAPs) for ADHD program, an 8-week, group-based mindfulness program for adults with ADHD, has been shown to reduce ADHD, depression, and anxiety symptoms. While promising, it is unknown as to whether the MAPs protocol is feasible, acceptable, and efficacious for college students with ADHD. The current study takes the first step towards enhanced study of mindfulness for college students with ADHD by testing the feasibility, acceptability, and preliminary efficacy of an adapted MAPs protocol delivered within university counseling center settings during the first semester of college. First-year college students with ADHD will be recruited at the University of Alabama and Wofford College. After developing and beta testing an adapted MAPs intervention at both sites, students will be randomized to adapted MAPs or Services-As-Usual (SAU; standard support services provided by the universities). Groups will include 10 first-year students and will be run over a 2-year period in the fall semesters (i.e., 4 MAPs groups across the two sites; total MAPs n = 40; total SAU n = 40). MAPs groups will be led by trained therapists in university counseling centers. Assessments will occur at pre, post, and 6-month follow-up using measures of ADHD, sluggish cognitive tempo (SCT), anxiety, and depression symptoms along with emotion regulation and mindfulness, our hypothesized mechanisms of change. Aims of the project are to: 1) adapt, manualize, and beta test the intervention, 2) conduct a pilot randomized controlled trial of adapted MAPs compared to SAU and examine feasibility and acceptability measures and clinical outcomes, and 3) examine whether the adapted MAPs intervention changes the targets hypothesized to be associated with changes in clinical outcomes (i.e., emotional regulation, mindfulness). If adequate feasibility, acceptability, and preliminary efficacy are documented, mindfulness for college students with ADHD can continue to be evaluated in larger trials. If ultimately found to be efficacious, this protocol has the potential to be widely disseminated within college counseling centers to have a broader public health impact for college students with ADHD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Mindful Awareness Practices (MAPs) for ADHD program is an 8-week, group-based mindfulness program for adults with ADHD.
Services-As-Usual includes the standard support services provided by universities
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses adult ADHD symptoms
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses adult sluggish cognitive tempo (SCT) symptoms
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses adult anxiety and depression symptoms
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses emotion regulation abilities in adults.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses the ability to regulate social stress in a laboratory paradigm.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses mind wandering in adults.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses mindfulness in adults.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This task measures the ability to sustain attention and mind wandering during task performance.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This task measures aspects of attention such as alerting, orienting, and executive control.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses self-rated executive functioning deficits in adults.
Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up
This measure assesses aspects of social functioning in adults.
Time frame: 6-month follow-up
This measure assess academic performance in the college setting.
Time frame: Up to 1-month post-treatment
This measure will assess participant satisfaction with the treatment.
Time frame: Weekly during treatment
This measure will assess whether the therapist delivered each intervention component and will ask the therapist to rate the degree of difficulty with implementation.
Time frame: Weekly sessions will be rated
This measure will involve a rating of how well the therapist implemented therapy session procedures.
Contact information is provided by the study sponsor or research team.
University of Alabama, Tuscaloosa
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04631042
Anxiety Disorders, Attention Deficit Disorder with Hyperactivity
Bethesda, Maryland, United States
View Trial DetailsNCT06847165
Alcohol-Induced Disorders, Alcohol-Related Disorders
Los Angeles, California, United States
View Trial DetailsNCT05608434
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Bethesda, Maryland, United States
View Trial DetailsNCT07665658
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Peshawar, KPK, Pakistan
View Trial Details